Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 1
2000 1
2006 1
2009 1
2010 1
2011 1
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.
Abnormally high levels of anti-collagen type IV IgG antibodies in the serum of patients with a clinically isolated syndrome correlate with an increased risk of conversion to MS.
Sadarzanska-Terzieva B, Tzvetanov P, Hegde V, Al-Hashel JY, Rousseff RТ, Haralanov L, Stamenov B, Atanassova M, Marinova I, Marinova A, Rousseva A. Sadarzanska-Terzieva B, et al. Among authors: stamenov b. Clin Neurol Neurosurg. 2015 Jun;133:30-3. doi: 10.1016/j.clineuro.2015.03.011. Epub 2015 Mar 17. Clin Neurol Neurosurg. 2015. PMID: 25837238
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG, Mattle HP, Rothwell PM; PERFORM Study Investigators. Bousser MG, et al. Cerebrovasc Dis. 2009;27(5):509-18. doi: 10.1159/000212671. Epub 2009 Apr 16. Cerebrovasc Dis. 2009. PMID: 19372653 Free article. Clinical Trial.
[Two cases of Hellp syndrome, clinics and therapy].
Khubchev G, Simeonov S, Mateeva N, Iordanova P, Stamenov B. Khubchev G, et al. Among authors: stamenov b. Akush Ginekol (Sofiia). 2006;45(1):48-51. Akush Ginekol (Sofiia). 2006. PMID: 16637320 Bulgarian. No abstract available.